Paula Lorgelly
Overview
Explore the profile of Paula Lorgelly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
689
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mu Y, Dashtban A, Mizani M, Tomlinson C, Mohamed M, Ashworth M, et al.
J R Soc Med
. 2024 Nov;
117(11):369-381.
PMID: 39603265
Objectives: To investigate healthcare utilisation and cost in individuals with long COVID (LC) at population level. Design: Case-control cohort analysis with multiple age-, sex-, ethnicity-, deprivation-, region- and comorbidity-matched control...
2.
Hunter S, Alexander Z, Crawford H, Te Ao B, Selak V, Mutu-Grigg J, et al.
J Paediatr Child Health
. 2024 Oct;
61(1):54-59.
PMID: 39462905
Aim: Hospitalisation rates for paediatric bone and joint infection (BJI) in New Zealand (NZ) are among the highest globally. This study aims to quantify hospitalisation costs of BJI in 2018-2019....
3.
Saygin Avsar T, Yang X, Lorgelly P
Soc Sci Med
. 2024 Aug;
357:117220.
PMID: 39153234
Background: The focus on health maximisation in a healthcare economic evaluation (HEE) - that is health gains are of equal value regardless of the recipient- has significant implications as health...
4.
Minhinnick A, Santos-Gonzalez F, Wilson M, Lorgelly P
Appl Health Econ Health Policy
. 2024 Jul;
PMID: 38980555
Objective: To identify how value is defined in studies that focus on the value of molecular testing in cancer and the extent to which broadening the conceptualisation of value in...
5.
Mortensen H, Populaire P, Hoffmann L, Moeller D, Appelt A, Nafteux P, et al.
Radiother Oncol
. 2023 Nov;
190:109980.
PMID: 37935284
No abstract available.
6.
Feng Y, Kristensen S, Lorgelly P, Meacock R, Nunez-Elvira A, Rodes-Sanchez M, et al.
Eur J Health Econ
. 2023 Oct;
25(5):857-876.
PMID: 37831298
Background: A Pay-for-Performance (P4P) programme, known as Prescribed Specialised Services Commissioning for Quality and Innovation (PSS CQUIN), was introduced for specialised services in the English NHS in 2013/2014. These services...
7.
Asif A, Nathan A, Ng A, Khetrapal P, Wai-Shun Chan V, Giganti F, et al.
BMJ Open
. 2023 Apr;
13(4):e070280.
PMID: 37019486
Introduction: Prostate MRI is a well-established tool for the diagnostic work-up for men with suspected prostate cancer (PCa). Current recommendations advocate the use of multiparametric MRI (mpMRI), which is composed...
8.
Yang W, Lee Y, Lorgelly P, Rogers S, Kim D
JAMA Otolaryngol Head Neck Surg
. 2023 Mar;
149(5):452-459.
PMID: 36951823
Importance: Several international guidelines have endorsed more conservative treatment of low-risk differentiated thyroid cancer (LRDTC), yet patients are facing more treatment options with similar oncologic outcomes and are expressing feelings...
9.
Forshaw D, Wall E, Prescott G, Dehbi H, Green A, Attree E, et al.
PLoS One
. 2023 Feb;
18(2):e0272472.
PMID: 36791116
Introduction: Long COVID (LC), the persistent symptoms ≥12 weeks following acute COVID-19, presents major threats to individual and public health across countries, affecting over 1.5 million people in the UK...
10.
Norman R, Mulhern B, Lancsar E, Lorgelly P, Ratcliffe J, Street D, et al.
Pharmacoeconomics
. 2023 Jan;
41(4):427-438.
PMID: 36720793
Background/aims: Discrete choice experiments (DCEs) with either duration included an attribute or with dead included as an option can be used as a stand-alone approach to value health states. This...